KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maxlinear (MXL) Research & Development (2016 - 2025)

Maxlinear (MXL) has disclosed Research & Development for 16 consecutive years, with $51.7 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 0.81% to $51.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $208.6 million through Dec 2025, down 7.37% year-over-year, with the annual reading at $208.6 million for FY2025, 7.37% down from the prior year.
  • Research & Development for Q4 2025 was $51.7 million at Maxlinear, down from $54.3 million in the prior quarter.
  • The five-year high for Research & Development was $80.4 million in Q2 2022, with the low at $47.2 million in Q2 2025.
  • Average Research & Development over 5 years is $63.9 million, with a median of $65.6 million recorded in 2022.
  • The sharpest move saw Research & Development soared 165.92% in 2021, then fell 21.41% in 2024.
  • Over 5 years, Research & Development stood at $73.3 million in 2021, then rose by 0.55% to $73.7 million in 2022, then decreased by 11.49% to $65.2 million in 2023, then dropped by 21.41% to $51.3 million in 2024, then grew by 0.81% to $51.7 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $51.7 million, $54.3 million, and $47.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.